SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-320293
Filing Date
2018-11-07
Accepted
2018-11-07 09:01:28
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d629611d10q.htm 10-Q 582602
2 EX-10.1 d629611dex101.htm EX-10.1 28521
3 EX-10.2 d629611dex102.htm EX-10.2 14585
4 EX-31.1 d629611dex311.htm EX-31.1 10778
5 EX-31.2 d629611dex312.htm EX-31.2 10758
6 EX-32.1 d629611dex321.htm EX-32.1 5457
  Complete submission text file 0001193125-18-320293.txt   2588586

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aqxp-20180930.xml EX-101.INS 360736
8 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20180930.xsd EX-101.SCH 30461
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20180930_cal.xml EX-101.CAL 40138
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20180930_def.xml EX-101.DEF 83708
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20180930_lab.xml EX-101.LAB 255404
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20180930_pre.xml EX-101.PRE 177360
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 181164872
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1